Otologic Pharmaceutics' Series A Round

Otologic Pharmaceutics raised a round of funding on April 03, 2014.

Otologic Pharmaceutics (OPI) is a development-stage biopharmaceutical company committed to developing and commercializing novel pharmacological solutions and approaches to treat hearing disorders. OPI…

Articles about Otologic Pharmaceutics' Series A Round: